granzabio.com · San Francisco · founded 2024 · team Team of cancer and immunology researchers from University of Oxford; focuses on developing 'attack particles' that deliver payloads to cytotoxic immune cells including T cells and NK cells · Seed ($7.14M raised) · trust 0/4
| Company Name | Granza Bio
source: https://www.granzabio.com |
| Tagline | Reprogramming Immunity for Target-Specific Medicines
source: https://www.granzabio.com |
| City | San Francisco
source: https://techcrunch.com/2024/07/03/granza-bio-grabs-7m-seed-from-felicis-and-yc-to-advance-delivery-of-cancer-treatments/ |
| Founded Year | 2024
source: https://www.prnewswire.com/news-releases/granza-bio-raises-7m-seed-funding-to-advance-the-delivery-of-cancer-treatment-and-genetic-medicines-302192267.html |
| Team Description | Team of cancer and immunology researchers from University of Oxford; focuses on developing 'attack particles' that deliver payloads to cytotoxic immune cells including T cells and NK cells
source: https://www.granzabio.com |
| Funding Stage | Seed ($7.14M raised)
source: https://www.prnewswire.com/news-releases/granza-bio-raises-7m-seed-funding-to-advance-the-delivery-of-cancer-treatment-and-genetic-medicines-302192267.html |
| Founders | Dr. Ashwin Jainarayanan, Dr. Ashwin Nandakumar
source: https://www.prnewswire.com/news-releases/granza-bio-raises-7m-seed-funding-to-advance-the-delivery-of-cancer-treatment-and-genetic-medicines-302192267.html |
| Company Description | Biotech company reprogramming immunity for target-specific medicines by developing programmable 'attack particles' that deliver therapeutics to cytotoxic immune cells (T cells, NK cells) for treating cancer, autoimmunity, and infectious diseases
source: https://www.granzabio.com |
| Public Contact Email | info@granzabio.com
source: https://www.granzabio.com |